Sector | Healthcare | Compare with Sector peers |
Industry | Hospital & Healthcare Services | Compare with Industry peers |
Website | http://www.apollohospitals.com | |
Market Cap | 88,715.85 Cr. | |
Enterprise Value(EV) | 90,856.85 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 54.90 | Trailing Twelve Months Ending 2023-12 |
Price-Earning Ratio (PE) | 112.40 | Trailing Twelve Months Ending 2023-12 |
Industry PE | 66.57 | Trailing Twelve Months Ending 2023-12 |
Book Value / Share | 469.72 | Trailing Twelve Months Ending 2023-12 |
Price to Book Value | 13.14 | Calculated using Price: 6,170.05 |
Dividend Yield | 0.24 | Period Ending 2023-03 |
No. of Shares Subscribed | 14.38 Cr. | 143,784,657 Shares |
FaceValue | 5 | |
About Apollo Hospitals Enterprise Ltd. | ||
The company has emerged as Asia's foremost integrated healthcare services provider and has a robust presence across the healthcare ecosystem, including Hospitals, Pharmacies, Primary Care & Diagnostic Clinics and several retail health models. The Group also has Telemedicine facilities across several countries, Health Insurance Services, Global Projects Consultancy, Medical Colleges, Medvarsity for E-Learning, Colleges of Nursing and Hospital Management and a Research Foundation. In addition, ‘ASK Apollo' - an online consultation portal and Apollo Home Health provide the care continuum. |
1 Day |
|
+1.39% |
1 Week |
|
-5.19% |
1 Month |
|
+0.30% |
3 Month |
|
+2.75% |
6 Month |
|
+23.65% |
1 Year |
|
+41.77% |
2 Year |
|
+35.10% |
5 Year |
|
+384.45% |
10 Year |
|
+593.13% |
9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 10.59 | 7.25 | 3.96 | 1.82 | 6.07 | 13.08 | 3.44 | 21.6 | 15.16 | |
Return on Capital Employed (%) | 12.09 | 9.05 | 7.62 | 7.12 | 10.24 | 17.13 | 9.32 | 24.92 | 17.78 | |
Return on Assets (%) | 5.51 | 3.4 | 1.62 | 0.66 | 2.05 | 3.9 | 1.1 | 8.15 | 5.79 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 3,171 | 3,331 | 3,313 | 3,252 | 3,334 | 3,339 | 4,603 | 5,623 | 6,197 | 6,509 | |
Non Curr. Liab. | 2,138 | 2,701 | 4,399 | 4,423 | 4,613 | 6,483 | 5,590 | 6,242 | 6,226 | 4,891 | |
Curr. Liab. | 1,076 | 1,250 | 963 | 1,567 | 1,955 | 2,337 | 2,038 | 2,434 | 3,325 | 3,780 | |
Minority Int. | 73 | 78 | 125 | 132 | 136 | 131 | 200 | 280 | 334 | 369 | |
Equity & Liab. | 6,459 | 7,360 | 8,800 | 9,374 | 10,037 | 12,290 | 12,431 | 14,579 | 16,082 | 15,548 | |
Non Curr. Assets | 4,520 | 5,385 | 6,671 | 7,154 | 7,756 | 9,643 | 8,789 | 10,519 | 11,745 | 10,661 | |
Curr. Assets | 1,939 | 1,975 | 2,129 | 2,220 | 2,282 | 2,647 | 3,642 | 4,061 | 4,337 | 4,888 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 6,459 | 7,360 | 8,800 | 9,374 | 10,037 | 12,290 | 12,431 | 14,579 | 16,082 | 15,548 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
Net Sales | 5,178 | 6,215 | 7,256 | 8,243 | 9,617 | 11,247 | 10,560 | 14,663 | 16,613 | 18,418 | |
Other Income | 37 | 53 | 44 | 34 | 32 | 33 | 49 | 78 | 90 | 95 | |
Total Income | 5,215 | 6,267 | 7,300 | 8,277 | 9,650 | 11,280 | 10,609 | 14,741 | 16,703 | 18,512 | |
Total Expenditure | -4,444 | -5,534 | -6,549 | -7,452 | -8,555 | -9,666 | -9,427 | -12,478 | -14,563 | -16,179 | |
PBIDT | 771 | 733 | 751 | 825 | 1,095 | 1,614 | 1,182 | 2,263 | 2,140 | 2,333 | |
Interest | -118 | -180 | -257 | -295 | -327 | -533 | -449 | -379 | -381 | -426 | |
Depreciation | -212 | -264 | -314 | -359 | -396 | -620 | -573 | -601 | -615 | -656 | |
Taxation | -130 | -97 | -91 | -112 | -173 | -225 | -85 | -477 | -256 | -444 | |
Exceptional Items | 13 | 16 | 198 | 61 | 294 | 2 | |||||
PAT | 325 | 235 | 131 | 60 | 199 | 435 | 136 | 1,101 | 888 | 809 | |
Minority Interest | 5 | 1 | 90 | 58 | 36 | 23 | 14 | -53 | -25 | -33 | |
Share Associate | 9 | 1 | -3 | 1 | 7 | -43 | 13 | ||||
Other Related Items | -11 | ||||||||||
Consolidated Net Profit | 340 | 226 | 221 | 117 | 236 | 455 | 150 | 1,056 | 819 | 789 | |
Adjusted EPS | 24 | 16 | 16 | 8 | 17 | 33 | 10 | 73 | 57 | 55 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 373 | 470 | 597 | 623 | 537 | 905 | 1,293 | 1,265 | 1,696 | 1,377 | |
Cash Fr. Inv. | -356 | -759 | -888 | -1,152 | -405 | -711 | -289 | -863 | -847 | -871 | |
Cash Fr. Finan. | -63 | 392 | 330 | 477 | -109 | -215 | -910 | -340 | -792 | -633 | |
Net Change | -46 | 103 | 39 | -52 | 24 | -20 | 95 | 61 | 57 | -127 | |
Cash & Cash Eqvt | 274 | 377 | 379 | 283 | 306 | 286 | 381 | 425 | 547 | 433 |
Tue, 16 Apr 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Annexure enclosed |
Sat, 06 Apr 2024
Sub: Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Submission Of Proceedings Of Annual General Meeting Of The Company Held On 30Th August 2023. Ref : Your Mail Dated 6Th April 2024 Response to your mail dated 6th April 2024 as per annexure enclosed |
Thu, 04 Apr 2024
Certificate Under Regulation 7(3) Of The SEBI (LODR) Regulations 2015 For The Period 1St April 2023 To 31St March 2024 Certificate under Regulation 7(3) of the SEBI (LODR) Regulations 2015 for the period 1st April 2023 to 31st March 2024 is enclosed. |
Fri, 19 Apr 2024 |
Higher Trade Quantity |
Making Lower Lows for 3 days |
Close Within 52 Week High Zone |
Making Lower Lows for 2 Days |
High Increase in 6 Months |